Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
In your 20s, it's crucial to know what financial mistakes to avoid. Discover key insights to help you manage your money wisely.
26,712 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
A classroom routine can spark a bold real estate plan. Learn a repeatable quick flip formula that turns a teacher int...
When rumors swirl about a star stepping away from the spotlight, a private reply can carry a big message. This articl...
AVX's Q4 2025 results shed light on growth, profitability, and the path ahead. This article breaks down the numbers, ...
A fresh look at SpaceX after its IPO reveals how investors price a company with rockets and recurring revenue. This w...
Gold’s surge in early 2026 has sparked crowded-trade warnings. This article ranks three retiree-friendly stock picks ...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Global markets pulled back after Iran strikes sparked a heated political response. Investors weigh consequences for s...
As Innodata prepares to unveil its Q1 2026 results, investors want clarity on growth drivers, margins, and the path t...
Sui Group's Q1 2026 results shed light on the company’s momentum and future path. This analysis breaks down the numbe...
Steris (STE) offers a steady earnings narrative in a healthcare environment shaped by infection control needs. This a...